Abstract: A series of novel 5-substituted 2-(arylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl) benzenesulfonamide derivatives 27-60 have been synthesized by the reaction of aminoguanidines with an appropriate phenylglyoxal hydrate in glacial acetic acid. A majority of the compounds showed cytotoxic activity toward the human cancer cell lines with IC 50 values below 100 µM. It was found that for the analogues 36-38 the naphthyl moiety contributed significantly to the anticancer activity. Cytometric analysis of translocation of phosphatidylserine as well as mitochondrial membrane potential and cell cycle revealed that the most active compounds 37 (HCT-116 and HeLa) and 46 (MCF-7) inhibited the proliferation of cells by increasing the number of apoptotic cells. Apoptotic-like, dose dependent changes in morphology of cell lines were also noticed after treatment with 37 and 46. Moreover, triazines 37 and 46 induced caspase activity in the HCT-116, HeLa and MCF-7 cell lines. Selected compounds were tested for metabolic stability in the presence of pooled human liver microsomes and NADPH, both R 2 and Ar = 4-CF 3 -C 6 H 4 moiety in 2-(R 2 -methylthio)-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides simultaneously increased metabolic stability. The results pointed to 37 as a hit compound with a good cytotoxicity against HCT-116 (IC 50 = 36 µM), HeLa (IC 50 = 34 µM) cell lines, apoptosis-inducing activity and moderate metabolic stability.
Introduction
For decades chemotherapeutics have played the most important role in the fight against cancer. Unfortunately, the serious toxicities of conventional cytotoxic medicines have impelled and are still impelling researchers to focus on the development of new potent and selective anticancer drugs.
Heterocyclic scaffolds, especially nitrogen-containing heterocyclic compounds, play an important role in the design of novel drugs because of their utility for various biological receptors with a high degree of binding affinity. Among the heterocycles, the triazines, with their wide biological profile, occupy a prominent position [1] . The 1,2,4-triazine ring as one of the most ubiquitous heterocycles in Nature, and it has been reported to possess a broad spectrum of biological properties, including anticonvulsant [2] , neuroprotective [3] , sedative [4] , anxiolytic [5] , benzodiazepine receptor inhibitory activity [6] , antiparkinson [7] , antidepressant [8] , anti-inflammatory [9] , antimicrobial [10] , antiparasitic [11] activities. Some 1,2,4-triazines have become well-known drugs, such as the antiviral azaribine [12] , the anticonvulsant lamotrigine [13] , the anti-inflammatory and analgesic apazone [14] , the antibacterial ceftriaxone [15] , the insecticide pymetrozine [16] or vardenafil, useful in the treatment of male erectile dysfunction [17] . In addition, there are also many reports indicating significant anticancer properties for the 1,2,4-triazine fragment. For example, tirapazamine (I, Figure 1 ) is currently in various clinical trial phases for the treatment of human non-small cell, cervical, ovarian, head and neck cancers. Tirapazamine works by inducing DNA damage in poorly oxygenated tumor cells [18] . The 6-azauridine II, known as an inhibitor of de novo pyrimidine biosynthesis, is an effective agent for remission induction of acute myelocytic leukemia in children [19] . Close analogs of 6-azauridine, S-alkyl derivatives of 1,2,4-triazinone III, show cytotoxic activities against human breast cancer (MCF-7), colon carcinoma (HCT-116) and hepatocellular carcinoma (Hep-G2) cell lines [20] . Some 1,2,4-triazine analogs IV have distinct antiptoliferative activities against non-small cell lung cancer (NCI-H460), breast cancer (MCF-7), CNS cancer (SF-268), with a low cytotoxicity [21] . 
Heterocyclic scaffolds, especially nitrogen-containing heterocyclic compounds, play an important role in the design of novel drugs because of their utility for various biological receptors with a high degree of binding affinity. Among the heterocycles, the triazines, with their wide biological profile, occupy a prominent position [1] . The 1,2,4-triazine ring as one of the most ubiquitous heterocycles in Nature, and it has been reported to possess a broad spectrum of biological properties, including anticonvulsant [2] , neuroprotective [3] , sedative [4] , anxiolytic [5] , benzodiazepine receptor inhibitory activity [6] , antiparkinson [7] , antidepressant [8] , anti-inflammatory [9] , antimicrobial [10] , antiparasitic [11] activities. Some 1,2,4-triazines have become well-known drugs, such as the antiviral azaribine [12] , the anticonvulsant lamotrigine [13] , the anti-inflammatory and analgesic apazone [14] , the antibacterial ceftriaxone [15] , the insecticide pymetrozine [16] or vardenafil, useful in the treatment of male erectile dysfunction [17] . In addition, there are also many reports indicating significant anticancer properties for the 1,2,4-triazine fragment. For example, tirapazamine (I, Figure 1 ) is currently in various clinical trial phases for the treatment of human non-small cell, cervical, ovarian, head and neck cancers. Tirapazamine works by inducing DNA damage in poorly oxygenated tumor cells [18] . The 6-azauridine II, known as an inhibitor of de novo pyrimidine biosynthesis, is an effective agent for remission induction of acute myelocytic leukemia in children [19] . Close analogs of 6-azauridine, S-alkyl derivatives of 1,2,4-triazinone III, show cytotoxic activities against human breast cancer (MCF-7), colon carcinoma (HCT-116) and hepatocellular carcinoma (Hep-G2) cell lines [20] . Some 1,2,4-triazine analogs IV have distinct antiptoliferative activities against non-small cell lung cancer (NCI-H460), breast cancer (MCF-7), CNS cancer (SF-268), with a low cytotoxicity [21] . Our systematic studies on arylsulfonamides has resulted in promising anticancer agents [22] [23] [24] [25] [26] [27] [28] [29] , and among them we have reported that some trisubstituted 1,2,4-triazines V (Figure 1 ), exhibited anticancer activity against colon, CNS, melanoma, ovarian, breast, renal, leukemia cell lines [29] . Searching for innovative low-molecular chemotherapeutics, a structure-based molecular hybridization strategy has been applied as a common approach to develop multi-targeted compounds [30] . Thus, we designed and synthesized a series of new 4-chloro-2-mercapto-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides VI (Figure 1 ), bearing a disubstituted 1,2,4-triazine and a Our systematic studies on arylsulfonamides has resulted in promising anticancer agents [22] [23] [24] [25] [26] [27] [28] [29] , and among them we have reported that some trisubstituted 1,2,4-triazines V (Figure 1 ), exhibited anticancer activity against colon, CNS, melanoma, ovarian, breast, renal, leukemia cell lines [29] . Searching for innovative low-molecular chemotherapeutics, a structure-based molecular hybridization strategy has been applied as a common approach to develop multi-targeted compounds [30] . Thus, we designed and synthesized a series of new 4-chloro-2-mercapto-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides VI (Figure 1 ), bearing a disubstituted 1,2,4-triazine and a 2-mercaptobenzenesulfonamide moiety in the molecular skeleton, (Figure 1 ) as potential anticancer agents. Various substituent groups were introduced to the triazine ring as well as the benzenesulfonamide fragment in positions 2 and 5 for structure-activity relationship (SAR) analysis. The prepared compounds were evaluated for their antiproliferative activities against three human cancer cell lines, namely, HCT-116 (colon cancer), HeLa (cervical cancer) and MCF-7 (breast cancer). For the most active compounds apoptosis-inducing activities on HCT-116, HeLa and MCF-7 cell lines were further investigated.
In vitro tests for metabolic stability, which is one of the important parameters characterizing pharmacokinetic properties of a molecule, were performed on selected compounds. The experiments were run in the presence of human liver microsomes and NADPH.
Results and Discussion

Chemistry
The starting substrates, 6-chloro-3-methylthio-7-R 1 -1,1-dioxo-1,4,2-benzodithiazines 1-5 [31, 32] , 3-amino-6-chloro-7-R 1 -1,1-dioxo-1,4,2-benzodithiazines 6-10 [33, 34] , N-(benzenesulfonyl)cyanamide potassium salts 11-18 [22, 25, 33, 35] as well as aminoguanidines 19-20 and 23-25 [29, 33, 35, 36] were prepared according to the respective known methods. Novel substrates 21-22 and 26 were synthesized analogously by the reaction of hydrazine monohydrochloride with the potassium salts 13-14 as was shown in Scheme 1. Finally, 4-chloro-2-(R 2 -methylthio)-5-R 1 -N-(5-aryl-1,2,4-triazin-3-yl) benzenesulfonamides 27-60 were readily obtained by treatment of aminoguanidines 19-26 with the appropriate phenylglyoxal hydrate in glacial acetic acid at reflux for 24-45 h as outlined in Scheme 2. 2-mercaptobenzenesulfonamide moiety in the molecular skeleton, (Figure 1 ) as potential anticancer agents. Various substituent groups were introduced to the triazine ring as well as the benzenesulfonamide fragment in positions 2 and 5 for structure-activity relationship (SAR) analysis. The prepared compounds were evaluated for their antiproliferative activities against three human cancer cell lines, namely, HCT-116 (colon cancer), HeLa (cervical cancer) and MCF-7 (breast cancer). For the most active compounds apoptosis-inducing activities on HCT-116, HeLa and MCF-7 cell lines were further investigated.
Results and Discussion
Chemistry
The starting substrates, 6-chloro-3-methylthio-7-R 1 -1,1-dioxo-1,4,2-benzodithiazines 1-5 [31, 32] , 3-amino-6-chloro-7-R 1 -1,1-dioxo-1,4,2-benzodithiazines 6-10 [33, 34] , N-(benzenesulfonyl)cyanamide potassium salts 11-18 [22, 25, 33, 35] as well as aminoguanidines 19-20 and 23-25 [29, 33, 35, 36] were prepared according to the respective known methods. Novel substrates 21-22 and 26 were synthesized analogously by the reaction of hydrazine monohydrochloride with the potassium salts 13-14 as was shown in Scheme 1. Finally, 4-chloro-2-(R 2 -methylthio)-5-R 1 -N-(5-aryl-1,2,4-triazin-3-yl) benzenesulfonamides 27-60 were readily obtained by treatment of aminoguanidines 19-26 with the appropriate phenylglyoxal hydrate in glacial acetic acid at reflux for 24-45 h as outlined in Scheme 2. (19) (20) (21) (22) (23) (24) (25) (26) The structures of the final compounds 27-60 were confirmed by IR, 1 H-NMR and 13 C-NMR spectroscopy. 1 H-NMR spectra showed the absence of characteristic of aminoguanidine NH signals at 4 and 6 ppm, confirming the success of the condensation reactions between the amine and carbonyl groups of the reagents leading to the heterocyclic ring formation. In addition, the presence in the 1 H-NMR spectra of a singlet at about 9 ppm corresponding to the H-6 proton in the 1,2,4-triazine fragment was observed. Moreover, X-ray analysis was done to confirm the proposed structures using the representative compound 59.
Compound 59 crystallizes in the triclinic system in the space group P1 . The asymmetric unit contains two sulfonamide molecules and four solvating dimethylformamide (DMF) molecules. The unit cell of the crystal contains two asymmetric parts (Z = 2). The two independent sulfonamide molecules have the same topological atom connectivity (constitution) but cannot be superimposed on each another (they are almost related by a mirror plane passing through SO2 group and bisecting the S-N-C and S-C-C planes). The solvent DMF molecules are not only filling the voids in the structure, but also participate in hydrogen bonding-two of carbonyl groups are acceptors of hydrogen from N-H of 1,2,4-triazine residue (O14-N4, O16-N9, see Table 1 ). The other two DMF molecules use their CO groups as acceptors for amidic NH groups (O13-N6, O15-N1, Table 1 ). Other intermolecular interactions responsible for crystal packing are π-π stacking operating between R1 (N3, C22, N4, N5, C23, C24) and R5 (C25-C30) with the distance between ring geometry centers (centroids) of 3.8252(3)Å and R6 (N8, C54, N9, N10, C55, C56) and R10 (C57-C52) 3.8952(3)Å. All other rings are separated by more than 4.4Å and interactions among them were neglected. The structures of the final compounds 27-60 were confirmed by IR, 1 H-NMR and 13 C-NMR spectroscopy. 1 H-NMR spectra showed the absence of characteristic of aminoguanidine NH signals at 4 and 6 ppm, confirming the success of the condensation reactions between the amine and carbonyl groups of the reagents leading to the heterocyclic ring formation. In addition, the presence in the 1 H-NMR spectra of a singlet at about 9 ppm corresponding to the H-6 proton in the 1,2,4-triazine fragment was observed. Moreover, X-ray analysis was done to confirm the proposed structures using the representative compound 59.
Compound 59 crystallizes in the triclinic system in the space group P1. The asymmetric unit contains two sulfonamide molecules and four solvating dimethylformamide (DMF) molecules. The unit cell of the crystal contains two asymmetric parts (Z = 2). The two independent sulfonamide molecules have the same topological atom connectivity (constitution) but cannot be superimposed on each another (they are almost related by a mirror plane passing through SO 2 group and bisecting the S-N-C and S-C-C planes). The solvent DMF molecules are not only filling the voids in the structure, but also participate in hydrogen bonding-two of carbonyl groups are acceptors of hydrogen from N-H of 1,2,4-triazine residue (O14-N4, O16-N9, see Table 1 ). The other two DMF molecules use their CO groups as acceptors for amidic NH groups (O13-N6, O15-N1, Table 1 ). Other intermolecular interactions responsible for crystal packing are π-π stacking operating between R1 (N3, C22, N4, N5, C23, C24) and R5 (C25-C30) with the distance between ring geometry centers (centroids) of 3.8252(3)Å and R6 (N8, C54, N9, N10, C55, C56) and R10 (C57-C52) 3.8952(3)Å. All other rings are separated by more than 4.4Å and interactions among them were neglected. The sulfonamide group seems to be deprotonated in the solid state, as there is a C-H bond from a DMF molecule directed to the sulfonamidic N ( Figure 2 ) which would not be beneficial without assumed ionization of the -SO 2 NH-fragment. Additionally, protonation of the nitrogen atom in position 2 of the 1,2,4-triazine is required by electrical neutrality and by formation of hydrogen bond to the carbonyl group from the neighbor DMF molecule. Thus, two charge-assisted hydrogen bonds are created: C-H¨¨¨N(´)-S and (+)N-H¨¨¨O between the sulfonamide and the solvating DMF. The sulfonamide group seems to be deprotonated in the solid state, as there is a C-H bond from a DMF molecule directed to the sulfonamidic N ( Figure 2 ) which would not be beneficial without assumed ionization of the -SO2NH-fragment. Additionally, protonation of the nitrogen atom in position 2 of the 1,2,4-triazine is required by electrical neutrality and by formation of hydrogen bond to the carbonyl group from the neighbor DMF molecule. Thus, two charge-assisted hydrogen bonds are created: C-H···N(−)-S and (+)N-H···O between the sulfonamide and the solvating DMF. Bond lengths within the triazine ring are not helpful to attribute double bonds in the substructure. The 1,2,4-triazine residue is flat and almost coplanar with 3,4-dimethoxyphenyl which may be a consequence of beneficial π-π interactions with the neighbor molecule in crystal. The second solvent DMF molecule forms hydrogen bond with the amide N-H proton donor in the other branch of the main molecule. The other functional groups are not unusual and their geometry will therefore not be further analyzed.
Biological Evaluations
Cytotoxic Activity
Compounds 27-60 were evaluated in vitro for their effects on the viability of three human cancer cell lines: HCT-116 (colon cancer), HeLa (cervical cancer) and MCF-7 (breast cancer). The concentration required for 50% inhibition of cell viability IC 50 was calculated and compared with the reference drug cisplatin, the results were shown in Table 2 . To describe of cytotoxic potency, the following scale was applied: IC 50 < 25 µM-very strong, 25 ď IC 50 ď 50 µM-strong, 50 < IC 50 < 75 µM-moderate, 75 ď IC 50 ď 100 µM-weak, IC 50 >100 µM-inactive compounds. 
a Analysis was performed using the MTT assay after 72 h of incubation. Values are expressed as the mean˘SD of at least three independent experiments; * Viability of cell lines at 100 µM of tested compounds were approximately 100%.
The most active compounds 37 and 38 belonged to the 1-naphthyl series (R 2 = 1-naphthyl) and showed outstanding average cytotoxic activity (47 µM and 50 µM, respectively) against all tested cell lines, HCT-116, HeLa and MCF-7. Moreover, compounds 34-36 and 46 moderately inhibited all cell lines viability, exhibiting average IC 50 values below 71 µM. Among tested analogues only six compounds (17.6%) were completely inactive with average IC 50 > 100 µM.
As shown in Table 2 , the HCT-116 cell line presented the relatively highest susceptibility and was affected by eleven compounds (33- We found that, among 4-chloro-2-(R 2 -methylthio)-5-R 1 -N-(5-aryl-1,2,4-triazin-3-yl)benzene -sulfonamides with R 2 = 1-naphthyl, presence of Ar = 4-CF 3 -C 6 H 4 group provided strong cytotoxicity of 37 toward the HeLa (IC 50 = 34 µM) as well as HCT-116 (IC 50 = 36 µM) cells and replacement of 1-naphthyl substituent in this compound by the smaller aromatic group, i.e., 34 (R 2 = 4-CF 3 -C 6 H 4 ), 40 (R 2 = 3,5-dimethylisoxazol-4-yl) caused decrease in activity to IC 50 ; 51-85 µM or the loss of activity when R 2 = Ph (compd 28, see Table 2 ). It should be noted, that replacement of Ar = 4-CF 3 -C 6 H 4 group (37) by Ar = 4-MeO-C 6 H 4 (38) or 3-F-C 6 H 4 (36) did not contribute to improving the anticancer activity. The presence of Ar = 4-CF 3 -C 6 H 4 also influenced the strongest cytotoxic activity of 46 (R 1 = 4-Cl-C 6 H 4 NHCO, R 2 = Ph, IC 50 = 59 µM) toward the MCF-7 cell line. Nevertheless, the exchange of R 1 = 4-Cl-C 6 H 4 NHCO in compd 46 to small methyl group strongly inactivate the compound 28 (R 1 = Me, R 2 = Ph) but introduction of 4-Me-C 6 H 4 NHCO as the R 1 substituent in compd 52 decreased its cytotoxic activity to IC 50 = 69 µM.
Investigation of Apoptotic Activity
The ability to induce apoptosis in cancer cells is a desired feature of a potential chemotherapeutic agent. Thus, the apoptosis-inducing activity was studied through biochemical markers, such as: DNA fragmentation, loss of mitochondrial membrane potential (∆ψ m ), phosphatidylserine translocation and caspase activation. Apoptotic-like changes in morphology of tested cell lines were also evaluated. The experiments were performed with the most active compounds (37 and 46) exhibited the highest activity in MTT tests.
Cell Morphology
To evaluate the changes in morphology of the treated cells, they were incubated with increasing concentrations of 37 (HCT-116, HeLa) or 46 (MCF-7) for 24 h and observed using light microscope. The most characteristic morphological changes (shrinkage of the cells, detachment from the surface) occurred in the HCT-116 and HeLa cells treated with 37 ( Figure 3 ).
Cell Cycle Analysis
One of the most common mechanisms in anticancer drug treatment is changes in cell cycle, which can be measured by DNA content [37] . Cell cycle distribution in HCT-116, HeLa and MCF-7 cells was examined to determine cycle arrest and/or presence of sub-G1 after treatment with compounds 37 and 46. Cells were coincubated with trazines and a reference drug (cisplatin) for 24 h, respectively. Cell populations data are expressed as the mean˘SD of at least three independent experiments.
Cell Morphology
To evaluate the changes in morphology of the treated cells, they were incubated with increasing concentrations of 37 (HCT-116, HeLa) or 46 (MCF-7) for 24 h and observed using light microscope. The most characteristic morphological changes (shrinkage of the cells, detachment from the surface) occurred in the HCT-116 and HeLa cells treated with 37 ( Figure 3) . 
Cell Cycle Analysis
One of the most common mechanisms in anticancer drug treatment is changes in cell cycle, which can be measured by DNA content [37] . Cell cycle distribution in HCT-116, HeLa and MCF-7 cells was examined to determine cycle arrest and/or presence of sub-G1 after treatment with compounds 37 and 46. Cells were coincubated with trazines and a reference drug (cisplatin) for 24 h, respectively. Cell populations data are expressed as the mean ± SD of at least three independent experiments. Sub-G1 cell population increased in dose dependent manner (HCT-116 from 3.6% ± 1.66% (control) to 48.6% ± 13.5%; HeLa from 5.7% ± 3.4% (control) to 21% ± 3.4%) after treatment with compound 37 for 24 h. Figure 4 shows one representative experiment. Similar results were obtained for MCF-7 cells coincubated with compound 46 for 24 h (from 5.0% ± 3.8% (control) to 20% ± 5.6%) (Figure 4) .
Coincubation of HCT-116, HeLa and MCF-7 with appropriate triazines (37 and 46) caused appearance of sub-G1 stage and high concentrations led to fragmentation of DNA, resulting in a sub-G0/G1 peak of cell cycle. A significant accumulation of the HCT-116, HeLa and MCF-7 population in the sub-G1 phase indicated that the cells had undergone programmed cell death (apoptosis) for all of the analyzed compounds. Triazine coincubation did not cause significant differences in the cell cycle phases of the analyzed cell lines. Coincubation of HCT-116, HeLa and MCF-7 with appropriate triazines (37 and 46) caused appearance of sub-G1 stage and high concentrations led to fragmentation of DNA, resulting in a sub-G0/G1 peak of cell cycle. A significant accumulation of the HCT-116, HeLa and MCF-7 population in the sub-G1 phase indicated that the cells had undergone programmed cell death (apoptosis) for all of the analyzed compounds. Triazine coincubation did not cause significant differences in the cell cycle phases of the analyzed cell lines. 
Mitochondrial Membrane Potential (∆ψ m ) Analysis
Loss of the mitochondrial membrane potential (∆ψ m ) is one of the earliest indicators of an apoptosis [38] . It can be detected using fluorescent dye JC-1 (5,5 1 ,6,6 1 -tetrachloro-1,1 1 ,3,3 1 -tetraethylbenzimidazolylcarbocyanine iodide) exited with blue laser. JC-1 spontaneously forms dimer complexes (J aggregates) with red fluorescent or remain as a monomers with green fluorescence in cells with high and low ∆ψ m , respectively.
As shown in Figure 5 HCT-116, HeLa and MCF-7 cells in the control group, high red fluorescence (J aggregates) were observed. However, exposure of cells even to low and moderate concentrations of compounds 37 and 46 remarkably decreased ∆ψ m which is the earliest indicators of an apoptotic cell death. As shown in Figure 5 HCT-116, HeLa and MCF-7 cells in the control group, high red fluorescence (J aggregates) were observed. However, exposure of cells even to low and moderate concentrations of compounds 37 and 46 remarkably decreased Δψm which is the earliest indicators of an apoptotic cell death.
Loss of
the mitochondrial membrane potential (Δψm) is one of the earliest indicators of an apoptosis [38]. It can be detected using fluorescent dye JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide) exited with blue laser. JC-1 spontaneously forms dimer complexes (J aggregates) with red fluorescent or remain as a monomers with green fluorescence in cells with high and low Δψm, respectively.
Translocation of Phosphatidylserine to Outer Leaflet of Cell Membrane
The quantification of cell death was evaluated by measuring the exposure of phosphatidylserine on the outer leaflet of plasma membrane. Four subpopulations were identified according to their fluorescence: PI-low/FITC-low (live cells), PI-high/FITC-low (necrotic cells), PI-low/FITC-high (early apoptotic cells), PI-high/FITC-high (late apoptotic cells).
Appearance of increased population of PI-low/FITC-high (early apoptotic cells), PI-high/FITC-high (late apoptotic cells) gates was noticed for HCT-116 and HeLa cells coincubated with compound 37 ( Figure 6 ). The increased levels of apoptotic cells were concentration dependent. For MCF-7 cells treated with compound 46 the results were not conclusive, as the differences between treated cells and control cells were statistically significant only for low 25 μM of 46 ( Figure 6 ). 
Caspase Activation
Caspase activation plays a central role in the execution of apoptosis and is required for the occurrence of its biochemical and morphological hallmarks, such as DNA fragmentation, formation of apoptotic bodies and chromatin condensation. The ability of the examined compounds to induce caspase activity was determined with the use of a fluorescent labeled caspase inhibitor, a carboxyfluorescein (FAM) derivative of valylalanylaspartic acid (VAD) fluoromethyl ketone (FMK).
FAM-VAD-FMK contains a target sequence recognized by active caspases (caspases 1 through 9). Binding to this sequence inhibits the enzymatic activity of caspases and allows for the determination of their activity through the direct measurement of fluorescent intensity of the bound inhibitor. The results of the research showed that the tested compounds 37 and 46 induced caspase activity in the examined cells lines, as shown by an increase in FAM-VAD-FMK fluorescence in the cell population with activated caspases (Figure 7) . The strongest influence on caspase activation was noticed for the HeLa cell line, where that cell population increased by 31% in the presence of 37 at a concentration of 100 µM. their activity through the direct measurement of fluorescent intensity of the bound inhibitor. The results of the research showed that the tested compounds 37 and 46 induced caspase activity in the examined cells lines, as shown by an increase in FAM-VAD-FMK fluorescence in the cell population with activated caspases (Figure 7) . The strongest influence on caspase activation was noticed for the HeLa cell line, where that cell population increased by 31% in the presence of 37 at a concentration of 100 μM. 
Metabolic Stability
Metabolism as one of the drugs' pharmacokinetic characteristics can be evaluated during the early preclinical stage to assessment of degree of drug candidate conversion into a set of metabolites. Metabolic stability can be assessed by incubation of a potent drug in a presence of liver microsomes and NADPH to give an insight to metabolic properties [39] [40] [41] .
For further evaluation of metabolic stability the compounds with outstanding activities and varied structural features including R 1 , R 2 and Ar substituents (30, 31, 34-38, 46, 47, 52) were selected. Human liver microsomes were chosen as a model enzymatic system and in vitro metabolic half-life was assessed (Table 3) .
Based on the enzymatic test results some structure-metabolic stability relationships can be noted. The most stable compound 34 bears a 4-CF 3 -C 6 H 4 moiety in both the R 1 and Ar positions. Replacement of Ar = 4-CF 3 -C 6 H 4 (34) by 4-MeO-C 6 H 4 (compound 35) resulted in decrease of the t 1/2 value from >60 to 42.4 min, while an analogous change between 46 and 47 caused a significant decrease of t 1/2 from >60 to 17.5 min. On the other hand, taking into account the results for 30 (Ar = 3-MeO-C 6 H 4 ) and 31 (Ar = 3,4-diMeO-C 6 H 3 ), it was found that an additional methoxy (MeO) group in the Ar substituent slightly decreased the metabolic stability. These facts suggest that the methoxy substituent is a major soft spot in the described series of compounds and moreover, its undesirable influence can be diminished by incorporation of CF 3 instead of a MeO substituent. Comparison of t 1/2 for 34 (R 1 = 4-CF 3 -C 6 H 4 ) and 37 (R 1 = 1-naphthyl) indicated that 1-naphthyl (R 1 ) also seems to decrease metabolic stability. We assumed that the undesirable influence of the 1-naphthyl (R 1 ) and 4-MeO-C 6 H 4 (Ar) substituents accelerated in the case of compound 38, which was characterized as the least stable derivative. Further synthesis in this group of compounds should avoid incorporation of the two abovementioned substituents. Although a 4-CF 3 -C 6 H 4 (R 1 ) substituent is preferable for metabolic stability in comparison with a 1-naphthyl moiety, the high biological response observed for 37 predisposes it to be a lead compound, as it shows a good balance between stability and cytotoxic properties.
In order to explain the differences between the metabolic stability of distinctive compounds (34-35, 37-38) we applied a tool accessible on-line for accurate prediction of xenobiotic metabolism sites, called XenoSite Cytochrome P450 Prediction Models [42] . Among the available models, one is able to predict which atoms on a molecule are likely to be oxidized by human liver microsomes. In silico results showed that the least stable derivative 38 has three more sites vulnerable for metabolic biotransformation than 34 (see Figure 8 ). Moreover, a slight decrease of metabolic stability of 35 and 37 compared to 34 may resulted from presence of additional sites of oxidation on methoxy group and methylene linker (35, Figure 8 ) as well as on methylene linker and naphthalene ring (37, Figure 8 ). Comparison of t1/2 for 34 (R 1 = 4-CF3-C6H4) and 37 (R 1 = 1-naphthyl) indicated that 1-naphthyl (R 1 ) also seems to decrease metabolic stability. We assumed that the undesirable influence of the 1-naphthyl (R 1 ) and 4-MeO-C6H4 (Ar) substituents accelerated in the case of compound 38, which was characterized as the least stable derivative. Further synthesis in this group of compounds should avoid incorporation of the two abovementioned substituents. Although a 4-CF3-C6H4 (R 1 ) substituent is preferable for metabolic stability in comparison with a 1-naphthyl moiety, the high biological response observed for 37 predisposes it to be a lead compound, as it shows a good balance between stability and cytotoxic properties.
In order to explain the differences between the metabolic stability of distinctive compounds (34-35, 37-38) we applied a tool accessible on-line for accurate prediction of xenobiotic metabolism sites, called XenoSite Cytochrome P450 Prediction Models [42] . Among the available models, one is able to predict which atoms on a molecule are likely to be oxidized by human liver microsomes. In silico results showed that the least stable derivative 38 has three more sites vulnerable for metabolic biotransformation than 34 (see Figure 8 ). Moreover, a slight decrease of metabolic stability of 35 and 37 compared to 34 may resulted from presence of additional sites of oxidation on methoxy group and methylene linker (35, Figure 8 ) as well as on methylene linker and naphthalene ring (37, Figure 8 ). [42] . Yellow color indicates more vulnerability to biotransformation than blue. Some significant differences are additionally pointed out by red arrows.
Materials and Methods
General Information
The melting points were uncorrected and measured using Boethius PHMK apparatus (Veb Analytic, Dresden, Germany). IR spectra were measured on Thermo Mattson Satellite FTIR spectrometer (Thermo Mattson, Madison, WI, USA) in KBr pellets; an absorption range was 400-4000 cm´1. 1 H-NMR and 13 C-NMR spectra were recorded on a Varian Gemini 200 apparatus (Varian, Palo Alto, CA, USA) or a Varian Unity Plus 500 apparatus. Chemical shifts are expressed at δ values relative to Me 4 Si (TMS) as an internal standard. The apparent resonance multiplicity is described as: s (singlet), d (doublet), dd (doublet of doublets), t (triplet), m (multiplet), and br (broad) signal. Elemental analyses were performed on 2400 Series II CHN Elemental Analyzer (PerkinElmer, Shelton, CT, USA) and the results were within˘0.4% of the theoretical values. Thin-layer chromatography (TLC) was performed on Kieselgel 60 F254 plates (Merck, Darmstadt, Germany) and visualized by UV. The commercially unavailable substrates were obtained according to the following methods described previously: 6-chloro-3-methylthio-7-R 1 -1,1-dioxo-1,4,2-benzo-dithiazines 1-5 [31, 32] , 3-amino-6-chloro-7-R 1 -1,1-dioxo-1,4,2-benzodithiazines 6-10 [33, 34] , N-(2-alkylthio -4-chloro-5-R 1 -benzenesulfonyl)cyanamide potassium salts 11-18 [22, 25, 33, 35 ], 1-amino-2-(4-chloro -5-R 1 -2-alkylthiobenzenesulfonyl)guanidines 19-20 and 23-25 [25, 29, 33, 35, 36] . The NMR spectra of newly synthesized compounds 21-22, 26-60 are given in the Supplementary Materials.
Synthesis
Procedures for the Preparation of Aminoguanidines 21-22 and 26
A mixture of the appropriate cyanamide potassium salt 13, 14 or 18 (7 mmol) and hydrazine monohydrochloride (0.48 g, 7 mmol) in anhydrous toluene (14 mL) was refluxed with stirring for 3-9 h. After cooling to room temperature, the reaction mixture was left in the freezer overnight. The precipitate was collected by filtration, dried and suspended in water (9 mL). The solid was separated and crystallized from ethanol (21) (22) or p-dioxane (26) . In this manner, the following aminoguanidines were obtained. 30-31, 42-44, 47) . The formed precipitate was collected by filtration, washed with glacial acetic acid (2ˆ1 mL) and dried. The final products 27-60 were purified as described below. 35 (s, 3H, CH 3 ), 3.80 (s, 3H, OCH 3 ), 3.88 (s, 3H, OCH 3 ), 4.28 (s, 2H, SCH 2 ), 7.08- 7.19 (m, 4H, arom), 7.28-7.32 (m, 2H, arom), 7.47 (s, 1H, H-3, arom) 
1-Amino-2-{4-chloro-5-methyl-2-[(naphthalen-1-ylmethyl)thio]benzenesulfonyl}guanidine (21). Starting from
N-{4-chloro-5-methyl-2-[(naphthalen-1-ylmethyl)thio]
X-ray Structure Determination
Crystals of 59 were grown from DMF solution. All specimens obtained were in form of very thin needles, having poor diffraction power. The copper radiation (almost no diffraction was observed with the Mo lamp) and long exposure times (4 min) were applied. The obtained signal to noise ratio was still smaller than usually, so final R int and R 1 indices are above the regular standards for small molecules. Nevertheless, structure solution is with no doubts generally correct. Diffraction intensity data were collected on an IPDS 2T dual-beam diffractometer (STOE & Cie GmbH, Darmstadt, Germany) at 120.(2) K with Cu-Kα radiation of a microfocus X-ray source (50 kV, 0.6 mA, λ = 154.186 pm, GeniX 3D Cu High Flux, Xenocs, Sassenage, France), The crystal was thermostated in nitrogen stream at 120 K using CryoStream-800 device (Oxford CryoSystem, Oxford, UK) during the entire experiment. Data collection and data reduction were controlled by X-Area 1.75 program [43] . An absorption correction was performed on the integrated reflections by a combination of frame scaling, reflection scaling and a spherical absorption correction. Outliers have been rejected according to Blessing's method [44] .
The structure was solved using direct methods with SHELXS-13 program and refined by SHELXL-2013 [45] program run under control of WinGx [46] . All C-H type hydrogen atoms were attached at their geometrically expected positions and refined as riding on heavier atoms with the usual constraints. The N-H hydrogen atoms were found in the differential Fourier electron density map and were refined without constraints.
Crystallographic data for the analysis have been deposited with the Cambridge Crystallographic data Centre, CCDC reference number is 1471508. Copies of this information may be obtained free of charge from CCDC, 12 Union Road, Cambridge, CB21EZ, UK (Fax: +44-1223-336033; E-mail: deposit@ccdc.cam.ac.uk or www: http://www.ccdc.cam.ac.uk).
Cell Culture and Cell Viability Assay
All chemicals, if not stated otherwise, were obtained from Sigma-Aldrich (St. Louis, MO, USA). The MCF-7 cell line was purchased from Cell Lines Services (Eppelheim, Germany), the HeLa and HCT-116 cell lines were obtained from the Department of Microbiology, Tumor and Cell Biology, Karolinska Institute (Stockholm, Sweden). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 units/mL penicillin, and 100 µg/mL streptomycin. Cultures were maintained in a humidified atmosphere with 5% CO 2 at 37˝C in an incubator (HeraCell, Heraeus, Langenselbold, Germany).
Cell viability was determined using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl -tetrazoliumbromide) assay. Stock solutions of the studied compounds were prepared in 100% DMSO. Working solutions were prepared by diluting the stock solutions with DMEM medium, the final concentration of DMSO did not exceed 0.5% in the treated samples. Cells were seeded in 96-well plates at a density of 5ˆ10 3 cells/well and treated for 72 h with the examined compounds in the concentration range 1-100 µM (1, 10, 25, 50 and 100 µM). Following treatment, MTT (0.5 mg/mL) was added to the medium and cells were further incubated for 2 h at 37˝C. Cells were lysed with DMSO and the absorbance of the formazan solution was measured at 550 nm with a plate reader (1420 multilabel counter, Victor, Jügesheim, Germany). The optical density of the formazan solution was measured at 550 nm with a plate reader (Victor 1420 multilabel counter). The experiment was performed in triplicate. Values are expressed as the mean˘SD of at least three independent experiments. 4-chloro-2-(R 2 -methylthio)-5-R 1 -N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides. The results pointed to 37 as a hit compound with a good biological response against HCT-116 (IC 50 = 36 µM) and HeLa (IC 50 = 34 µM) cell lines with apoptosis-inducing activity, and satisfactory metabolic stability.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/21/ 6/808/s1.
